Injectable Fillers : Panel Discussion, Controversies, and Techniques - 09/04/18
, Lisa Bunin, MD c, Rebecca Fitzgerald, MD dRésumé |
Injectable products are now being designed to treat specific areas of the face, including the lower lid/cheek region, the midface, and circumoral rhytids. Expert injectors from 3 core disciplines (facial plastic surgery, oculoplastic surgery, and dermatology) were asked to discuss their approaches to the midface, lower lid, and cheek region and their opinions about using cannulas versus needles. The authors describe their techniques for avoiding and managing filler complications. They give insight into how their techniques have changed over the past few years and their use of new products that have been developed.
Le texte complet de cet article est disponible en PDF.Keywords : Injectable fillers, Cannula, Tear trough, Injectable complications
Plan
| Disclosure: R. Fitzgerald acts as a speaker, trainer, and member of the advisory boards for Allergan, Galderma, and Merz. L. Bunin has nothing to disclose. T.C. Kontis is a member of the Speaker Bureau and injector trainer for Galderma and Allergan. |
Vol 26 - N° 2
P. 225-236 - mai 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
